176 related articles for article (PubMed ID: 210608)
1. Serum somatomedin A in growth retarded children.
Hizuka N; Takano K; Shizume K; Kawai K
Acta Endocrinol (Copenh); 1978 Aug; 88(4):625-32. PubMed ID: 210608
[TBL] [Abstract][Full Text] [Related]
2. Comparison of growth and somatomedin C responses following growth hormone treatment in children with small-for-date short stature, significant idiopathic short stature and hypopituitarism.
Grunt JA; Howard CP; Daughaday WH
Acta Endocrinol (Copenh); 1984 Jun; 106(2):168-74. PubMed ID: 6539552
[TBL] [Abstract][Full Text] [Related]
3. Results of 1-year growth hormone (GH)-releasing hormone-(1-44) treatment on growth, somatomedin-C, and 24-hour GH secretion in six children with partial GH deficiency.
Rochiccioli PE; Tauber MT; Coude FX; Arnone M; Morre M; Uboldi F; Barbeau C
J Clin Endocrinol Metab; 1987 Aug; 65(2):268-74. PubMed ID: 3110202
[TBL] [Abstract][Full Text] [Related]
4. Growth failure, somatomedin and growth hormone levels in juvenile diabetes mellitus--a pilot study.
Nash H
Aust N Z J Med; 1979 Jun; 9(3):245-9. PubMed ID: 223535
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of the somatomedin C/insulin-like growth factor I: response to exogenous growth hormone (GH) in GH-deficient children.
Blethen SL; Daughaday WH; Weldon VV
J Clin Endocrinol Metab; 1982 May; 54(5):986-90. PubMed ID: 7037825
[TBL] [Abstract][Full Text] [Related]
6. Serum somatomedin-C in hypopituitarism and in other disorders of growth.
D'Ercole AJ; Underwood LE; Van Wyk JJ
J Pediatr; 1977 Mar; 90(3):375-81. PubMed ID: 839329
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of somatomedin A and growth during long-term treatment of patients with pituitary dwarfism with human growth hormone.
Takano K; Hizuka N; Shizume K; Hasumi Y
Acta Endocrinol (Copenh); 1979 Nov; 92(3):385-97. PubMed ID: 229685
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of growth hormone (GH) and somatomedin C in idiopathic GH-deficient subjects by intermittent pulsatile administration of synthetic human pancreatic tumor GH-releasing factor.
Borges JL; Blizzard RM; Evans WS; Furlanetto R; Rogol AD; Kaiser DL; Rivier J; Vale W; Thorner MO
J Clin Endocrinol Metab; 1984 Jul; 59(1):1-6. PubMed ID: 6427267
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunological determination of somatomedin B in healthy children and in children with growth disturbances.
Wirth S; Schönberger W; Roth A; Grimm W
Acta Endocrinol (Copenh); 1983 Jan; 102(1):16-20. PubMed ID: 6823777
[TBL] [Abstract][Full Text] [Related]
10. Effect of growth hormone-releasing factor on plasma growth hormone, prolactin and somatomedin C in hypopituitary and short normal children.
Van Vliet G; Bosson D; Robyn C; Craen M; Malvaux P; Vanderschueren-Lodeweyckx M; Wolter R
Horm Res; 1985; 22(1-2):32-45. PubMed ID: 3928475
[TBL] [Abstract][Full Text] [Related]
11. Plasma somatomedin activity and urinary hydroxyproline excretion during administration of human growth hormone in children with short stature. Short-term effects.
Wit JM; Van den Brande JL
Horm Res; 1984; 19(4):205-15. PubMed ID: 6745841
[TBL] [Abstract][Full Text] [Related]
12. Combined test of hypothalamic-pituitary function in growth retarded children treated with growth hormone. I. Secretion of growth hormone and somatomedin before and after treatment.
Kastrup KW; Andersen H; Eskildsen PC; Jacobsen BB; Krabbe S; Petersen KE
Acta Paediatr Scand Suppl; 1979; 277():8-13. PubMed ID: 396757
[TBL] [Abstract][Full Text] [Related]
13. Growth failure with normal serum RIA-GH and low somatomedin activity: somatomedin restoration and growth acceleration after exogenous GH.
Kowarski AA; Schneider J; Ben-Galim E; Weldon VV; Daughaday WH
J Clin Endocrinol Metab; 1978 Aug; 47(2):461-4. PubMed ID: 263308
[TBL] [Abstract][Full Text] [Related]
14. [Somatomedin activity and growth hormone secretion in children with idiopathic growth retardation (author's transl)].
Carrascosa A; Prevot C; Evain D; Czernichow P; Rappaport R
Arch Fr Pediatr; 1980 Oct; 37(8):515-9. PubMed ID: 7447606
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone treatment for short stature.
Van Vliet G; Styne DM; Kaplan SL; Grumbach MM
N Engl J Med; 1983 Oct; 309(17):1016-22. PubMed ID: 6684729
[TBL] [Abstract][Full Text] [Related]
16. Somatomedin binding proteins in GH-deficient children with normal plasma somatomedin levels.
Cohen DA; Blethen SL
J Clin Endocrinol Metab; 1983 Mar; 56(3):461-6. PubMed ID: 6185524
[TBL] [Abstract][Full Text] [Related]
17. [Somatomedin and growth hormone in patients with retarded growth and atrophy due to congenital heart disease or malabsorption (author's transl)].
Kerpel-Fronius E; Kiss S; Kardos G; Gács G
Monatsschr Kinderheilkd (1902); 1977 Aug; 125(8):783-6. PubMed ID: 904638
[TBL] [Abstract][Full Text] [Related]
18. [Somatomedins].
Ranke MB; Blum W; Bierich JR
Wien Klin Wochenschr; 1987 May; 99(9):306-12. PubMed ID: 3604213
[TBL] [Abstract][Full Text] [Related]
19. Differences in somatomedin-C between short-normal subjects and those of normal height.
Cacciari E; Cicognani A; Pirazzoli P; Tassoni P; Salardi S; Capelli M; Zucchini S; Natali G; Righetti F; Ballardini D
J Pediatr; 1985 Jun; 106(6):891-4. PubMed ID: 4039752
[TBL] [Abstract][Full Text] [Related]
20. Correlation between pituitary growth hormone reserve and degree of growth failure in children with short stature.
Kajiwara S; Igarashi N; Imura E; Sato T
Eur J Pediatr; 1988 Aug; 147(6):584-7. PubMed ID: 3141190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
